NEW YORK, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in BioXcel Therapeutics, Inc. ("BioXcel" or the "Company") (NASDAQ:BTAI) of a class action securities lawsuit.
CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of BioXcel investors who were adversely affected by alleged securities fraud between December 15, 2021 and June 28, 2023. Follow the link below to get more information and be contacted by a member of our team:
https://zlk.com/pslra-1/bioxcel-lawsuit-submission-form?prid=45703&wire=3
BTAI investors may also contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500.
CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (1) the Company lacked adequate internal controls over protocol adherence and data integrity; (2) as a result, the Company's principal investigator failed ...
BTAI) Investors of a Class Action Lawsuit and Upcoming Deadline>Full story available on Benzinga.com